Dr Agarwals Eye Hospital Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Dr Agarwals Eye Hospital Ltd is ₹ 5280 as of 30 Oct 15:30 . The P/E Ratio of Dr Agarwals Eye Hospital Ltd changed from 14.3 on March 2022 to 32.4 on March 2026 . This represents a CAGR of 17.77% over 5 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 25.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 years The Market Cap of Dr Agarwals Eye Hospital Ltd changed from ₹ 147.16 crore on March 2021 to ₹ 2271 crore on March 2026 . This represents a CAGR of 57.79% over 6 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 47.02 crore on March 2023 to ₹ 14.34 crore on March 2026 . This represents a CAGR of -25.69% over 4 years The revenue of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 144.93 crore as compare to the Mar '26 revenue of ₹ 121.58 crore. This represent the growth of 19.21% The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 45.22 crore as compare to the Mar '26 ebitda of ₹ 35.3 crore. This represent the growth of 28.1% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dr Agarwals Eye Hospital Ltd changed from ₹ 14.11 crore to ₹ 23.38 crore over 9 quarters. This represents a CAGR of 25.16% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Dr Agarwals Eye Hospital Ltd changed from 5.85 % on March 2022 to 4.82 % on March 2026 . This represents a CAGR of -3.80% over 5 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dr Agarwals Eye Hospital Ltd

Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994.
The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu.
Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division.
It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others.
It has presence in Tamil Nadu, Kerala and Rajasthan states. The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Dr Agarwals Eye Hospital Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Dr Agarwals Eye Hospital Ltd is 2,551 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd?

As of October 31, 2026, the Dr Agarwals Eye Hospital Ltd stock price is INR ₹5280.15. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.82.

How do dividend payouts of Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Dr Agarwals Eye Hospital Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.